Core Points - Golden Heaven Group Holdings Ltd. announced a share consolidation on a 25 for 1 ratio, effective May 9, 2025, to comply with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing [1][2] - The share consolidation will convert every 25 ordinary shares into one ordinary share automatically, with no fractional shares issued [3] - The authorized share capital will change from US$200,600,000 into a new structure, resulting in approximately 2,972,944 Class A ordinary shares and approximately 73,600 Class B ordinary shares [4] Company Overview - Golden Heaven operates amusement parks, water parks, and complementary recreational facilities in China, offering a variety of experiences including rides, water attractions, and performances [5]

Core Points - Linkage Global Inc has announced a share consolidation on a 10 for 1 ratio effective April 7, 2025, to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on Nasdaq [1][2] - The share consolidation will result in each 10 ordinary shares automatically combining into one ordinary share, with no fractional shares issued [3] - Following the consolidation, the Company's authorized share capital will change from US$2,500,000 divided into 9,980,000,000 Class A ordinary shares to US$2,500,000 divided into 998,000,000 Class A ordinary shares, with the par value increasing from US$0.00025 to US$0.0025 [4] Company Overview - Linkage Global Inc is a holding company incorporated in the Cayman Islands, operating through subsidiaries in Japan, Hong Kong, and mainland China [5] - The Company specializes in cross-border e-commerce integrated services, with two main business lines: cross-border sales and integrated e-commerce services [5]

Core Viewpoint - China SXT Pharmaceuticals, Inc. has regained compliance with Nasdaq's Minimum Bid Price Requirement after a share consolidation and has closed the matter with Nasdaq [1][4]. Group 1: Compliance Notification - The company received a Compliance Notice from Nasdaq on March 13, 2025, confirming it has met the Minimum Bid Price Requirement [1]. - Previously, on October 3, 2024, the company was notified of its failure to maintain a minimum bid price of US$1.00 per share for 30 consecutive business days [2]. - The company was given until April 1, 2025, to regain compliance under Nasdaq Listing Rules [2]. Group 2: Share Consolidation - To address the Minimum Bid Price deficiency, the company executed a share consolidation on February 25, 2025, consolidating every eight ordinary shares into one [3]. - Following the consolidation, the company achieved a closing bid price of at least US$1.00 per share for 10 consecutive business days from February 25, 2025, to March 12, 2025 [4]. Group 3: Company Overview - China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou City, Jiangsu Province, China [5]. - The company specializes in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (TCMPs) and TCM Homologous Supplements (TCMHS) [5].